In GC clinical samples, we found patients with high expression of both lncSLCO1C1 and SSRP1 have a much shorter overall survival than those with low expressions of both, highlighting the importance and functional relevance of lncSLCO1C1 and SSRP1 in GC. This evidence concerns the gene SSRP1 and gastric cancer.